Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122118422 | 12211842 | 2 | F | 20130322 | 20160805 | 20160325 | 20160819 | EXP | US-JNJFOC-20160319882 | JANSSEN | 59.12 | YR | A | M | Y | 0.00000 | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122118422 | 12211842 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | TABLET | |||||||
| 122118422 | 12211842 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 10 MG, 15 MG, 20 MG | Y | N | UNKNOWN | 0 | TABLET | ||||||
| 122118422 | 12211842 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 10 MG, 15 MG, 20 MG | Y | N | UNKNOWN | 0 | TABLET | ||||||
| 122118422 | 12211842 | 4 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 202439 | TABLET | |||||||
| 122118422 | 12211842 | 5 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | Y | 0 | 325 | MG | TABLET | |||||||
| 122118422 | 12211842 | 6 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG | Y | 0 | TABLET | ||||||||
| 122118422 | 12211842 | 7 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | Y | 0 | 81 | MG | TABLET | |||||||
| 122118422 | 12211842 | 8 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | 0 | UNSPECIFIED | |||||||||
| 122118422 | 12211842 | 9 | SS | ANAPROX | NAPROXEN SODIUM | 1 | Oral | Y | 0 | 550 | MG | TABLETS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122118422 | 12211842 | 1 | Atrial fibrillation |
| 122118422 | 12211842 | 2 | Atrial fibrillation |
| 122118422 | 12211842 | 3 | Cerebrovascular accident prophylaxis |
| 122118422 | 12211842 | 4 | Cerebrovascular accident prophylaxis |
| 122118422 | 12211842 | 5 | Atrial fibrillation |
| 122118422 | 12211842 | 6 | Atrial fibrillation |
| 122118422 | 12211842 | 7 | Atrial fibrillation |
| 122118422 | 12211842 | 8 | Atrial fibrillation |
| 122118422 | 12211842 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122118422 | 12211842 | HO |
| 122118422 | 12211842 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122118422 | 12211842 | Catheter site haemorrhage | |
| 122118422 | 12211842 | Coagulopathy | |
| 122118422 | 12211842 | Lower gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122118422 | 12211842 | 1 | 20130321 | 201303 | 0 | |
| 122118422 | 12211842 | 2 | 2013 | 20130817 | 0 | |
| 122118422 | 12211842 | 3 | 2013 | 20130817 | 0 | |
| 122118422 | 12211842 | 4 | 20130321 | 201303 | 0 | |
| 122118422 | 12211842 | 5 | 201308 | 0 | ||
| 122118422 | 12211842 | 6 | 201303 | 0 | ||
| 122118422 | 12211842 | 7 | 2013 | 201308 | 0 | |
| 122118422 | 12211842 | 8 | 201303 | 0 |